ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,007,000 | -56.0% | 129,126 | -41.0% | 0.01% | -78.6% |
| Q3 2021 | $6,831,000 | -25.3% | 218,959 | -15.8% | 0.03% | -31.7% |
| Q2 2021 | $9,143,000 | -46.0% | 259,907 | -45.9% | 0.04% | -47.4% |
| Q1 2021 | $16,923,000 | -32.4% | 480,067 | -28.1% | 0.08% | -42.6% |
| Q4 2020 | $25,045,000 | +8.2% | 667,703 | -3.7% | 0.14% | -8.1% |
| Q3 2020 | $23,144,000 | +930.0% | 693,535 | +717.6% | 0.15% | +825.0% |
| Q2 2020 | $2,247,000 | +813.4% | 84,826 | +778.6% | 0.02% | +700.0% |
| Q4 2019 | $246,000 | +547.4% | 9,655 | +412.7% | 0.00% | – |
| Q3 2019 | $38,000 | -68.9% | 1,883 | -50.0% | 0.00% | -100.0% |
| Q1 2019 | $122,000 | +165.2% | 3,766 | +100.0% | 0.00% | – |
| Q4 2018 | $46,000 | – | 1,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |